Patents by Inventor Suresh Katti

Suresh Katti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING INFLAMMATORY OCULAR DISEASES WITH COMPLEMENT FACTOR H
    Publication number: 20240024416
    Abstract: The present disclosure relates to dosage regimens of complement factor H (CFH) protein for treating patients having inflammatory ocular diseases or conditions (e.g., age-related macular degeneration or early-onset macular dystrophies). The present disclosure also provides methods of treating patients having inflammatory ocular diseases, disorders, or conditions (e.g., age-related macular degeneration) using complement factor H (CFH) based on the levels of certain protein biomarkers, such as complement components and inflammation markers, in ocular samples of the patients.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 25, 2024
    Inventors: Suresh Katti, Scott Lauder, Robyn Biggs, Walter Strapps, Lenore von Krusenstiern
  • METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH RECOMBINANT CFH PROTEINS
    Publication number: 20220395557
    Abstract: The present disclosure provides methods for treating, preventing, or inhibiting diseases in patients having one or more mutations in complement factor H (CFH), complement component 3 (C3), and complement factor B (CFB). Also provided are combination therapies comprising a CFH protein and a VEGF antagonist for treating neovascularization-associated ocular diseases.
    Type: Application
    Filed: October 23, 2020
    Publication date: December 15, 2022
    Inventors: James McLaughlin, Lisa Huang, Scott Lauder, Suresh Katti
  • METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH CFH-ENCODING VECTORS
    Publication number: 20220396807
    Abstract: The present disclosure provides methods for treating, preventing, or inhibiting diseases in patients having one or more mutations in complement factor H (CFH), complement component 3 (C3), and complement factor B (CFB) by administering to the patients a recombinant adeno-associated virus (rAAV) vector encoding a CFH polypeptide or biologically active fragment and/or variant thereof.
    Type: Application
    Filed: October 23, 2020
    Publication date: December 15, 2022
    Inventors: James McLaughlin, Lisa Huang, Suresh Katti, Walter Strapps, Melissa Deck
  • METHODS FOR TREATING PATIENTS HAVING CFI MUTATIONS WITH RECOMBINANT CFI PROTEINS
    Publication number: 20220347265
    Abstract: The present disclosure provides methods for treating, preventing, or inhibiting diseases in patients having one or more CFI mutations.
    Type: Application
    Filed: October 23, 2020
    Publication date: November 3, 2022
    Inventors: James McLaughlin, Lisa Huang, Scott Lauder, Suresh Katti, Adam Tellier